MCT

MCT, Medium-chain triglycerides, Coconut Oil

MCTs are a type of saturated fatty acids, found mainly in coconut oil. They are used for many outcomes, like fat loss, cognition improvement, performance enhancement and others, but its most reliable use is for ketogenic diets and lipolysis. Because of its unique absorption metabolism, it can also be used as an energy booster, but most evidence are not specifically clear about all those effects.

Nutraceutic

  • Origin Plant Based, Animal Product
  • Source Milk, Coconut
  • Type Saturated fatty acid, MCT, Nootropic

Weight Management

Total body weight takes into account all body elements, such as organs, muscles, bones, fluids, fat, etc. The weight loss process depends on a negative energy balance (spending more calories than the ones consumed), but there are substances that can help the body to increase this deficit. Among them, there are thermogenics, fibers, appetite suppressants, fat absorption blockers and some others.
  • Thermogenic Effect

    Thermogenesis is the body's energy production process, responsible for regulating internal temperature and all natural energy processes. There are some compounds that amplify this process, such as caffeine and other thermogens.
  • Age Range Children (0-12), Teenagers (13-19), Adults (20-59), Seniors (>60)
  • Toxicity May be toxic in high doses
  • Side effects Nausea, Diarrhea, Abdominal Pain, Gastrointestinal Disturbs
  • Warnings Diabetes, Hypertension, Hepatic Diseases, High Cholesterol

Why be Careful

MTC supplementation seems to be safe for most people, and there are no interactions with specific medications untill now. Due to the resulting production of ketones it is thought that it could increase the risk of ketoacidosis, a very serious condition that can occur in type 1 diabetics, infecctions and liver diseases. People with high cholesterol should be aware that MCTs change blood lipid patterns.

References

  1. ^ Babayan V. Medium chain length fatty acid esters and their medical and nutritional applicationsJ Am Oil Chem Soc. (1981)
  2. ^ Sigalet DL, Martin G. Lymphatic absorption of glucose and fatty acids as determined by direct measurementJ Pediatr Surg. (1999)
  3. ^ Sigalet DL, Winkelaar GB, Smith LJ. Determination of the route of medium-chain and long-chain fatty acid absorption by direct measurement in the ratJPEN J Parenter Enteral Nutr. (1997)
  4. ^ USDA Food Composition Database Nutrient list for C6:0, C8:0, and C10:0.
  5. a b c Bach AC, Babayan VK. Medium-chain triglycerides: an updateAm J Clin Nutr. (1982)
  6. ^ Ghosh S, Bhattacharyya DK. Medium-chain fatty acid-rich glycerides by chemical and lipase-catalyzed polyester-monoester interchange reactionJ Amer Oil Chem Soc. (1997)
  7. ^ Mu H, Porsgaard T. The metabolism of structured triacylglycerolsProg Lipid Res. (2005)
  8. ^ Mansbach CM 2nd, Gorelick F. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicronsAm J Physiol Gastrointest Liver Physiol. (2007)
  9. ^ McLaughlin J, et al. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motilityGastroenterology. (1999)
  10. ^ Symersky T, et al. The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretionClin Physiol Funct Imaging. (2002)
  11. a b You YQ, et al. Effects of medium-chain triglycerides, long-chain triglycerides, or 2-monododecanoin on fatty acid composition in the portal vein, intestinal lymph, and systemic circulation in ratsJPEN J Parenter Enteral Nutr. (2008)
  12. ^ Iber FL. Relative rates of metabolism MCT, LCT and ethanol in manZ Ernahrungswiss Suppl. (1974)
  13. ^ Borel P, et al. Chylomicron beta-carotene and retinyl palmitate responses are dramatically diminished when men ingest beta-carotene with medium-chain rather than long-chain triglyceridesJ Nutr. (1998)
  14. a b Swift LL, et al. Medium-chain fatty acids: evidence for incorporation into chylomicron triglycerides in humansAm J Clin Nutr. (1990)
  15. ^ Rubio-Gozalbo ME, et al. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspectsMol Aspects Med. (2004)
  16. ^ Bach A, Phan T, Metais P. Effect of the fatty acid composition of ingested fats on rat liver intermediary metabolismHorm Metab Res. (1976)
  17. ^ Bach A. Oxaloacetate deficiency in MCT-induced ketogenesisArch Int Physiol Biochim. (1978)
  18. ^ McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body productionAnnu Rev Biochem. (1980)
  19. ^ Yeh YY, Zee P. Relation of ketosis to metabolic changes induced by acute medium-chain triglyceride feeding in ratsJ Nutr. (1976)
  20. ^ Bach A, et al. Ketogenic response to medium-chain triglyceride load in the ratJ Nutr. (1977)
  21. ^ McGarry JD, Foster DW. The regulation of ketogenesis from octanoic acid. The role of the tricarboxylic acid cycle and fatty acid synthesisJ Biol Chem. (1971)
  22. a b Vandenberghe C, et al. Tricaprylin alone increases plasma ketone response more than coconut oil or other medium chain triglycerides: an acute crossover study in healthy adultsCurr Dev Nutr. (2017)
  23. ^ Adkison KD, Shen DD. Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporterJ Pharmacol Exp Ther. (1996)
  24. a b Chang P, et al. Seizure control by decanoic acid through direct AMPA receptor inhibitionBrain. (2016)
  25. a b Van Wymelbeke V, Louis-Sylvestre J, Fantino M. Substrate oxidation and control of food intake in men after a fat-substitute meal compared with meals supplemented with an isoenergetic load of carbohydrate, long-chain triacylglycerols, or medium-chain triacylglycerolsAm J Clin Nutr. (2001)
  26. a b Rolls BJ, et al. Food intake in dieters and nondieters after a liquid meal containing medium-chain triglyceridesAm J Clin Nutr. (1988)
  27. ^ St-Onge MP, et al. Impact of medium and long chain triglycerides consumption on appetite and food intake in overweight menEur J Clin Nutr. (2014)
  28. a b c Van Wymelbeke V, et al. Influence of medium-chain and long-chain triacylglycerols on the control of food intake in menAm J Clin Nutr. (1998)
  29. ^ Stubbs RJ, Harbron CG. Covert manipulation of the ratio of medium- to long-chain triglycerides in isoenergetically dense diets: effect on food intake in ad libitum feeding menInt J Obes Relat Metab Disord. (1996)
  30. a b Krotkiewski M. Value of VLCD supplementation with medium chain triglyceridesInt J Obes Relat Metab Disord. (2001)
  31. a b c d Han JR, et al. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjectsMetabolism. (2007)
  32. a b Martin K, et al. Ketogenic diet and other dietary treatments for epilepsyCochrane Database Syst Rev. (2016)
  33. ^ Lima PA, Sampaio LP, Damasceno NR. Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsyClinics (Sao Paulo). (2014)
  34. ^ Masino SA, Rho JM. Mechanisms of Ketogenic Diet Action.
  35. ^ Groleau V, et al. Long-term impact of the ketogenic diet on growth and resting energy expenditure in children with intractable epilepsyDev Med Child Neurol. (2014)
  36. ^ Bergqvist AG, et al. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic dietAm J Clin Nutr. (2008)
  37. a b Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsyNeurology. (1971)
  38. ^ Huttenlocher PR. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsyPediatr Res. (1976)
  39. ^ Trauner DA. Medium-chain triglyceride (MCT) diet in intractable seizure disordersNeurology. (1985)
  40. ^ Sills MA, et al. The medium chain triglyceride diet and intractable epilepsyArch Dis Child. (1986)
  41. a b Schwartz RH, et al. Ketogenic diets in the treatment of epilepsy: short-term clinical effectsDev Med Child Neurol. (1989)
  42. a b Schwartz RM, Boyes S, Aynsley-Green A. Metabolic effects of three ketogenic diets in the treatment of severe epilepsyDev Med Child Neurol. (1989)
  43. ^ Liu YM. Medium-chain triglyceride (MCT) ketogenic therapyEpilepsia. (2008)
  44. ^ Liu YM, Wang HS. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic dietsBiomed J. (2013)
  45. ^ Neal EG, et al. Growth of children on classical and medium-chain triglyceride ketogenic dietsPediatrics. (2008)
  46. a b c d Neal EG, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsyEpilepsia. (2009)
  47. a b Azzam R, Azar NJ. Marked Seizure Reduction after MCT SupplementationCase Rep Neurol Med. (2013)
  48. a b c Reger MA, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adultsNeurobiol Aging. (2004)
  49. a b c Henderson ST, et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trialNutr Metab (Lond). (2009)
  50. a b Rebello CJ, et al. Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trialBBA Clin. (2015)
  51. ^ Cunnane SC, et al. Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer’s DiseaseFront Mol Neurosci. (2016)
  52. a b Tsuji H, et al. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and womenJ Nutr. (2001)
  53. ^ Tsai YH, et al. Mechanisms mediating lipoprotein responses to diets with medium-chain triglyceride and lauric acidLipids. (1999)
  54. a b c d Temme EH, Mensink RP, Hornstra G. Effects of medium chain fatty acids (MCFA), myristic acid, and oleic acid on serum lipoproteins in healthy subjectsJ Lipid Res. (1997)
  55. a b Swift LL, et al. Plasma lipids and lipoproteins during 6 d of maintenance feeding with long-chain, medium-chain, and mixed-chain triglyceridesAm J Clin Nutr. (1992)
  56. a b Hill JO, et al. Changes in blood lipids during six days of overfeeding with medium or long chain triglyceridesJ Lipid Res. (1990)
  57. a b HASHIM SA, ARTEAGA A, VAN ITALLIE TB. Effect of a saturated medium-chain triglyceride on serum-lipids in manLancet. (1960)
  58. a b St-Onge MP, et al. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oilJ Am Coll Nutr. (2008)
  59. ^ Tremblay AJ, et al. Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant menAm J Clin Nutr. (2014)
  60. ^ van Schalkwijk DB, et al. Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementationPLoS One. (2014)
  61. ^ Turkenkopf IJ, Maggio CA, Greenwood MR. Effect of high fat weanling diets containing either medium-chain triglycerides or long-chain triglycerides on the development of obesity in the Zucker ratJ Nutr. (1982)
  62. a b c Kasai M, et al. Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humansAsia Pac J Clin Nutr. (2003)
  63. ^ Xue C, et al. Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjectsEur J Clin Nutr. (2009)
  64. ^ Zhang YH, et al. Medium- and long-chain fatty acid triacylglycerol reduce body fat and serum triglyceride in overweight and hypertriglyceridemic subjectsZhonghua Yu Fang Yi Xue Za Zhi. (2009)
  65. ^ Liu Y, et al. A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjectsAsia Pac J Clin Nutr. (2009)
  66. ^ Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys LectureCirculation. (1997)
  67. ^ Zhang Y, et al. Medium- and long-chain triacylglycerols reduce body fat and blood triacylglycerols in hypertriacylglycerolemic, overweight but not obese, Chinese individualsLipids. (2010)
  68. ^ Asakura L, et al. Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjectsAm J Clin Nutr. (2000)
  69. ^ Cater NB, Heller HJ, Denke MA. Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humansAm J Clin Nutr. (1997)
  70. ^ UZAWA H, et al. HYPERGLYCERIDEMIA RESULTING FROM INTAKE OF MEDIUM CHAIN TRIGLYCERIDESAm J Clin Nutr. (1964)
  71. a b Eckel RH, et al. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjectsDiabetes. (1992)
  72. ^ Airhart S, et al. A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot StudyJ Clin Endocrinol Metab. (2016)
  73. ^ Hayes KC. Medium-chain triacylglycerols may not raise cholesterolAm J Clin Nutr. (2000)
  74. ^ Pi-Sunyer FX, Hashim SA, Van Itallie TB. Insulin and ketone responses to ingestion of medium and long-chain triglycerides in manDiabetes. (1969)
  75. ^ Tamir I, et al. Effects of a single oral load of medium-chain triglyceride on serum lipid and insulin levels in manJ Lipid Res. (1968)
  76. ^ Yost TJ, et al. Dietary substitution of medium chain triglycerides in subjects with non-insulin-dependent diabetes mellitus in an ambulatory setting: impact on glycemic control and insulin-mediated glucose metabolismJ Am Coll Nutr. (1994)
  77. ^ Souza PF, Williamson DH. Effects of feeding medium-chain triacylglycerols on maternal lipid metabolism and pup growth in lactating ratsBr J Nutr. (1993)
  78. ^ Lieber CS, et al. Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liverJ Clin Invest. (1967)
  79. ^ Johnson RC, et al. Medium-chain-triglyceride lipid emulsion: metabolism and tissue distributionAm J Clin Nutr. (1990)
  80. ^ Watkins JB, et al. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath testsGastroenterology. (1982)
  81. ^ Metges CC, Wolfram G. Medium- and long-chain triglycerides labeled with 13C: a comparison of oxidation after oral or parenteral administration in humansJ Nutr. (1991)
  82. ^ Schoeller DA, et al. 13C abundances of nutrients and the effect of variations in 13C isotopic abundances of test meals formulated for 13CO2 breath testsAm J Clin Nutr. (1980)
  83. a b c Papamandjaris AA, et al. Endogenous fat oxidation during medium chain versus long chain triglyceride feeding in healthy womenInt J Obes Relat Metab Disord. (2000)
  84. a b Binnert C, et al. Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerolsAm J Clin Nutr. (1998)
  85. ^ Carnitine Palmitoyltransferase 1A Deficiency.
  86. ^ Geliebter A, et al. Overfeeding with medium-chain triglyceride diet results in diminished deposition of fatAm J Clin Nutr. (1983)
  87. ^ Dulloo AG, et al. Differential effects of high-fat diets varying in fatty acid composition on the efficiency of lean and fat tissue deposition during weight recovery after low food intakeMetabolism. (1995)
  88. ^ Crozier G, et al. Metabolic effects induced by long-term feeding of medium-chain triglycerides in the ratMetabolism. (1987)
  89. ^ Lavau MM, Hashim SA. Effect of medium chain triglyceride on lipogenesis and body fat in the ratJ Nutr. (1978)
  90. ^ Papamandjaris AA, White MD, Jones PJ. Components of total energy expenditure in healthy young women are not affected after 14 days of feeding with medium-versus long-chain triglyceridesObes Res. (1999)
  91. ^ Roynette CE, et al. Structured medium and long chain triglycerides show short-term increases in fat oxidation, but no changes in adiposity in menNutr Metab Cardiovasc Dis. (2008)
  92. ^ Assunção ML, et al. Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesityLipids. (2009)
  93. ^ Clegg ME. Medium-chain triglycerides are advantageous in promoting weight loss although not beneficial to exercise performanceInt J Food Sci Nutr. (2010)
  94. ^ Does medium chain triglyceride play an ergogenic role in endurance exercise performance?.
  95. ^ Hawley JA, Brouns F, Jeukendrup A. Strategies to enhance fat utilisation during exerciseSports Med. (1998)
  96. ^ Horowitz JF, et al. Preexercise medium-chain triglyceride ingestion does not alter muscle glycogen use during exerciseJ Appl Physiol. (2000)
  97. ^ Misell LM, et al. Chronic medium-chain triacylglycerol consumption and endurance performance in trained runnersJ Sports Med Phys Fitness. (2001)
  98. ^ Goedecke JH, et al. The effects of medium-chain triacylglycerol and carbohydrate ingestion on ultra-endurance exercise performanceInt J Sport Nutr Exerc Metab. (2005)
  99. ^ Angus DJ, et al. Effect of carbohydrate or carbohydrate plus medium-chain triglyceride ingestion on cycling time trial performanceJ Appl Physiol. (2000)
  100. ^ Kehayoglou K, et al. The effect of medium-chain triglyceride on 47 calcium absorption in patients with primary biliary cirrhosisGut. (1973)
  101. ^ Harrison JE, et al. Effect of medium chain triglyceride on fecal calcium losses in pancreatic insufficiencyClin Biochem. (1973)
  102. ^ Tandon RK, Rodgers JB Jr, Balint JA. The effects of medium-chain triglycerides in the short bowel syndrome. Increased glucose and water transportAm J Dig Dis. (1972)
  103. a b c Traul KA, et al. Review of the toxicologic properties of medium-chain triglyceridesFood Chem Toxicol. (2000)
  104. ^ Nair AB, Jacob S. A simple practice guide for dose conversion between animals and humanJ Basic Clin Pharm. (2016)
  105. White MD, Papamandjaris AA, Jones PJ. Enhanced postprandial energy expenditure with medium-chain fatty acid feeding is attenuated after 14 d in premenopausal womenAm J Clin Nutr. (1999)